Kalbe Farma Tbk - ADR
PTKFY
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.92B
Close$
$24.69
190.5% upside
Current Fair Value
190.5% upsideUndervalued by 190.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.92 Billion |
|---|---|
| Enterprise Value | $-4,032,111,291,450.00 |
| Dividend Yield | $0.22 (2.55%) |
| Earnings per Share | $16176 |
| Beta | 0.05 |
| Outstanding Shares | 226,244,300 |
Return
| Return on Equity | 12.09% |
|---|---|
| Return on Assets | 8.89% |
| Return on Invested Capital | 14.21% |
Valuation & Multiples
| P/E Ratio | 9.86 |
|---|---|
| PEG | -7065.24 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 1.09 |
| Enterprise Value to EBIT | 8.32 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Kalbe Farma Tbk
12,806 employees
CEO: Vidjongtius PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. T...